FOR INSTITUTIONAL & PROFESSIONAL CLIENTS (in the UK, EEA and Switzerland) and QUALIFIED INSTITUTIONAL BUYERS (in the USA) ONLY.

The information contained herein is proprietary and confidential.

FOR INTENDED AUDIENCES ONLY – NOT FOR WIDER DISTRIBUTION.

THIS MATERIAL DOES NOT CONSTITUTE AN OFFER OR SOLICITATION IN ANY JURISDICTION WHERE OR TO ANY PERSON TO WHOM IT WOULD BE UNAUTHORIZED OR UNLAWFUL TO DO SO.

This information is being furnished through Acrisure Re Corporate Advisory & Solutions, LLC (“ARCAS US”) and is for informational purposes only and does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities. Securities and Investment Banking Services are offered through Acrisure Re Corporate Advisory & Solutions, LLC, Member FINRA, SIPC.

Acrisure Re Corporate Advisory & Solutions Limited (“ARCAS UK” together with ARCAS US, “ARCAS” or “we,” “us,” or “our”) and its affiliates provide the information contained on this website on an as is basis solely for the use of the intended recipient and for informational purposes only. ARCAS UK makes no representation, guarantee, or warranty, whether express or implied, including any as to the accuracy, completeness, timeliness, satisfactory quality or fitness for any particular purpose or use of any information contained in the document.

This website is intended strictly for investors who are “Eligible Counterparties” or “Professional Clients” as defined by the FCA, Institutional Investors as defined by FINRA and Qualified Institutional Buyers (QIBs) as defined in Rule 144A under the Securities Act. This website and the information contained in it is not intended for any other persons and must not be distributed as such. It is the responsibility of the prospective investors to comply with all the applicable laws in their jurisdiction, including any financial services laws and regulations in their country or territory in connection with any application to participate in the opportunity described on our website, including obtaining any required governmental or other consent and adhering to any other formality prescribed.

The analysis and opinions expressed herein are based on publicly available data as of the date of publication and are subject to change without notice. While we have made every effort to ensure the accuracy of the content, we do not warrant or guarantee its completeness, timeliness, or accuracy. The author(s) and publisher(s) disclaim all liability for any errors or omissions and any reliance on the information contained herein.

We may have relied on data provided by an insurer, reinsurer, managing general agent, public data and other sources when preparing this information. Such information, and our related calculations, projections, forecasts and estimates, are derived from or based on sources believed by us to be reliable, but we do not guarantee the correctness or accuracy of such information, calculations, projections, forecasts or estimates. All forward-looking statements in this document are subject to various risks and uncertainties that could cause results to differ materially from expectations. Users should not place reliance on such forward-looking statements, or any other information contained herein.

Information contained on this website is not an offering document and does not constitute investment advice. Whilst ARCAS and its affiliates have made this website available to you, it is not an offer to buy or sell, or a solicitation of an offer to buy or sell any security or instrument, including but not limited to any debt or equity securities that may be issued by a special purpose vehicle.

Information contained on this website is not intended to provide, and should not be relied upon for, accounting, legal, or tax advice or investment recommendations, should the recipient require such advice it is encouraged to seek such advice independently. Information contained on this website does not constitute a personal recommendation as defined by the Financial Conduct Authority (“FCA”), or consider the particular investment objectives, financial situations, or needs of individual investors. You shall be responsible for evaluating the risks and merits involved in any investment described on this website.

Different instruments involve different levels of exposure to risk and may therefore be more or less appropriate to your circumstances, objectives or risk appetite. You should not enter into a transaction in respect of any instrument unless you are satisfied that you understand its nature and the extent of its potential risk.

We shall not be liable, under any circumstances, to any user or other person for losses of any kind (including but not limited to special, indirect, incidental, consequential, or punitive damages), or for lost profits or lost opportunities associated with this information including but not limited to the underlying data, the actuarial methods used in the analysis of the data and the resulting information. We do not accept any liability associated with the use of this information and no duty of liability is owed to any party unless agreed otherwise in writing by us.

Any articles published and the information contained on this website constitute our property, which may include trade secrets, and such document and information shall not be distributed by the recipient to any other party without our permission. Our rights in respect of this are reserved, including seeking damages for unauthorised use of the website and its content.

Nothing in this document is intended to create any legally binding arrangements between any parties referred to herein.

Acrisure Re Corporate Advisory & Solutions Limited is a registered company in England and Wales, Company No. 13447220. Registered address: 9th Floor, 40 Leadenhall Street, London, EC3A 2BJ, United Kingdom

Acrisure Re Corporate Advisory & Solutions Limited is authorised and regulated by the Financial Conduct Authority (Firm Reference Number 964339).

Acrisure Re Corporate Advisory & Solutions, LLC, Member: FINRA / SIPC. 1 Liberty Plaza, New York, NY 10006 United States.

Important Notice

This website is intended solely for Professional Clients, Eligible Counterparties (each as defined in the FCA Handbook), Institutional Investors, Qualified Institutional Buyers (as defined in Rule 144A under the U.S. Securities Act of 1933), Qualified Purchasers (as defined in Section 2(a)(51) of the U.S. Investment Company Act of 1940), and other persons who may lawfully receive the information contained herein under the laws and regulations applicable in their jurisdiction.

FOR PROFESSIONAL CLIENTS, ELIGIBLE COUNTERPARTIES, QUALIFIED INSTITUTIONAL BUYERS, QUALIFIED PURCHASERS AND OTHER ELIGIBLE PERSONS ONLY.

FOR INTENDED AUDIENCES ONLY.

The information contained on this website is not directed at, and must not be accessed, relied upon or acted upon by, Retail Clients (as defined in the FCA Handbook), retail customers (as defined in Regulation Best Interest, 17 CFR § 240.15l-1), or members of the general public.

To the extent that any content on this website constitutes a financial promotion for the purposes of section 21 of the Financial Services and Markets Act 2000 (“FSMA”), it is directed only at person who qualify as Professional Clients or Eligible Counterparties under the FCA Rules, or who otherwise fall within an exemption under the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “FPO”), including, where applicable, investment professionals and high net worth companies, unincorporated associations and other qualifying persons. To the extent that any content on this website may be deemed a communication subject to U.S. federal or state securities laws, it is directed only at persons who qualify as Qualified Institutional Buyers, Qualified Purchasers, or other persons to whom such communications may lawfully be made under applicable U.S. law.

NOTHING ON THIS WEBSITE CONSTITUTES, OR SHALL BE DEEMED TO CONSTITUTE, AN OFFER, INVITATION OR SOLICITATION TO BUY, SELL, SUBSCRIBE FOR OR ISSUE ANY SECURITIES IN ANY JURISDICTION, OR TO ANY PERSON, WHERE THE MAKING OF SUCH OFFER, INVITATION OR SOLICITATION WOULD BE UNAUTHORISED, UNLAWFUL OR OTHERWISE CONTRARY TO APPLICABLE LAW OR REGULATION.

Acrisure Re Corporate Advisory & Solutions, LLC (“ARCAS US”) is a broker-dealer registered with the U.S. Securities and Exchange Commission (“SEC”) and a member of the Financial Industry Regulatory Authority (“FINRA”) and the Securities Investor Protection Corporation (“SIPC”). Acrisure Re Corporate Advisory & Solutions Limited (“ARCAS UK”) is authorised and regulated by the Financial Conduct Authority (“FCA”) (FRN: 964339). ARCAS US and ARCAS UK (together, “ARCAS” or “we,” “us,” or “our”) and their affiliates provide the information contained on this website on an “as is” basis solely for the use of the intended recipient and for informational purposes only. The information contained herein does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities, and should not be construed as investment advice, investment research, legal, tax or regulatory advice, or a recommendation to buy, sell or otherwise transact in any investment, financial instrument, product or service.

No representation, warranty or undertaking, express or implied, is given as to the accuracy, completeness, timeliness, reliability, satisfactory quality or fitness for a particular purpose of any information contained on this website.

Capital is at risk. Past performance is not a guarantee of future results and is not a reliable indicator of future performance.

ARCAS is entitled to rely upon the confirmations provided by visitors to this website. To the fullest extent permitted by applicable law, ARCAS accepts no responsibility or liability for any loss, damage, claim or consequence arising from any false, inaccurate or misleading confirmation regarding investor status, eligibility or regulatory classification.

Access to this website may be restricted by the laws and regulations of certain jurisdictions, including restrictions administered by the U.S. Department of the Treasury’s Office of Foreign Assets Control (“OFAC”) and other sanctions authorities. By accessing this website, you represent that you are not a person or entity subject to U.S., UK, EU, or UN sanctions. It is the responsibility of each visitor to ensure that access to this website is permitted under the laws and regulations applicable to them. Persons who are subject to such restrictions must not access this website.

Confirmation

By selecting “Accept”, you represent, warrant and confirm that:

  • I am a PROFESSIONAL CLIENT, ELIGIBLE COUNTERPARTY (each as defined in the FCA Handbook), QUALIFIED INSTITUTIONAL BUYER (as defined in Rule 144A under the
    U.S. Securities Act of 1933), QUALIFIED PURCHASER (as defined in Section 2(a)(51) of the U.S. Investment Company Act of 1940), INSTITUTIONAL INVESTOR, or other person who may lawfully access this website under the laws and regulations applicable in my jurisdiction;
  • I am not a Retail Client (as defined in the FCA Handbook), a retail customer (as defined in SEC Regulation Best Interest), or a member of the general public;
  • I am accessing this website in compliance with all applicable laws and regulations;
  • Where relevant, I fall within a category of person to whom communications of this nature may lawfully be made, including under the UK Financial Services and Markets Act 2000 and the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, and/or under applicable U.S. federal and state securities laws, including the U.S. Securities Act of 1933 and the U.S. Securities Exchange Act of 1934;
  • I understand and acknowledge that this website is directed solely at PROFESSIONAL CLIENTS, ELIGIBLE COUNTERPARTIES, QUALIFIED INSTITUTIONAL BUYERS, QUALIFIED PURCHASERS, INSTITUTIONAL INVESTORS and other eligible persons, and is not intended for Retail Clients, retail customers, or members of the general public;
  • I understand that the information contained on this website is provided for informational purposes only and does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities, investment advice, investment research, an offer to sell, or a solicitation, invitation or recommendation to engage in any investment activity;
  • I acknowledge that Acrisure Re Corporate Advisory & Solutions, LLC (a broker-dealer registered with the SEC and member of FINRA and SIPC) and Acrisure Re Corporate Advisory & Solutions Limited (authorised and regulated by the FCA) (FRN: 964339), including their affiliates, are entitled to rely on the confirmations provided above and that I am responsible for ensuring that access to this website is permitted under the laws and regulations applicable to me.
  • I am not a person or entity subject to sanctions administered by the U.S. Department of the Treasury’s Office of Foreign Assets Control (“OFAC”), the UK Office of Financial Sanctions Implementation (“OFSI”), the European Union, or the United Nations;
  • I am of legal age and have the legal capacity to access this website and to act on the information contained herein;

 

If you do not meet all of the above criteria, or are uncertain whether you do, you must select “Decline” and must not proceed to the website.

Transaction Overview

LONDON, UK – Acrisure Re Corporate Advisory & Solutions Limited is pleased to announce its role as financial advisor to FTV Capital in connection with a significant growth equity investment into Carbon Underwriting Limited (Carbon), the market-leading delegated authority underwriting specialist with its own Lloyd’s syndicate.

FTV’s investment will support Carbon’s growth across its delegated underwriting platform, fund continued development of its proprietary Graphene data and analytics technology, deepen its AI capabilities and support international expansion, including the build-out of its US business. Carbon has experienced exceptional growth between 2023 and 2026, with gross written premium increasing from £150 million to £471 million at market-leading loss ratios.

Acrisure Re Corporate Advisory & Solutions Limited served as financial advisor to FTV Capital on the transaction.

*The experiences of the featured client are not indicative of the experience of all clients, and you should not expect similar results. Past performance may not be indicative of future results.

Client Testimonial

“Throughout the establishment of Corinthian, the ARCAS team leveraged creativity and technical expertise to execute on a complicated, fast-moving, multi-party transaction. The team engineered an innovative deal structure that utilized a London Bridge 2.0 PCC for ourselves, arranged Tier 1 debt to enhance capital returns to all counterparties, and delivered granular analytics that clearly articulated potential investor outcomes. The depth of understanding of Lloyd’s capital frameworks, reporting requirements and processes, along with the close coordination with legal partners ensured a smooth, meticulous process from start to finish. The ARCAS team were some of the most commercial counterparties we have worked with, remaining focused on material items, while flexibly crafting a transaction that worked for all parties involved. We look forward to building Corinthian together in the coming years.”*

Gallatin Point Capital LLC  

*The experiences of the featured client are not indicative of the experience of all clients, and you should not expect similar results. Past performance may not be indicative of future results.

Transaction Overview

On December 31, 2025, Goodlife Solutions, Inc., the intermediate holding company of Blue Cross Blue Shield of Nebraska, Inc. (“BCBSNE”), completed a $100 million Senior Term Loan offering. BCBSNE is the leading health insurance provider in Nebraska, and the proceeds from the Senior Term Loan will be down streamed to BCBSNE in the form of a surplus note. This additional surplus will further strengthen BCBSNE’s already solid financial position as it advances its growth strategy across government programs.

BCBSNE is a member of the Blue Cross Blue Shield Association, which is comprised of over 30 plans and collectively provides healthcare coverage to nearly one third of all Americans. Founded in 1939, BCBSNE is the leading health insurer for group markets in Nebraska. The company generates approximately $2.6 billion in annual revenue and serves more than 600,000 members.

The Senior Term Loan was privately placed by a syndicate led by Synovus Bank.

Acrisure Re Corporate Advisory and Solutions (“ARCAS”) served as exclusive financial advisor to BCBSNE for this transaction.

Client Testimonial

“Acrisure’s responsiveness and reputation helped make this deal possible. Their preliminary work, connections, and due diligence guided us through our search for top quality partners that met our needs at favorable terms. Tom and his team walked with us through the entire process and helped us find the right deal and the right fit for our needs. I highly recommend Acrisure for anyone looking for a trusted advisor in this space.”

Acrisure Re Corporate Advisory & Solutions

ARCAS served as the exclusive financial advisor to Blue Cross Blue Shield of
Nebraska, providing:

  • Identification of syndicate participants
  • Advisory support on loan structuring and negotiations
*The experiences of the featured client are not indicative of the experience of all clients, and you should not expect similar results. Past performance may not be indicative of future results.